Joode, K.D.
72  results:
?
 
?
 
?
 
?
10

The genomic and transcriptomic landscape of advanced renal ..:

de Joode, K ; van de Geer, W S ; van Leenders, G J L H...
https://research.rug.nl/en/publications/d6ece3d8-93c4-4778-87d2-f45880728caa.  , 2023
 
?
 
?
13

Life-prolonging treatment restrictions and outcomes in pati..:

de Joode, Karlijn ; Tol, Jolien ; Hamberg, Paul...
de Joode , K , Tol , J , the DOCC investigators , Hamberg , P , Cloos , M , Kastelijn , E A , Borgers , J S W , Nuij , V J A A , Klaver , Y , Herder , G J M , Mutsaers , P G N J , Dumoulin , D W , Oomen-de Hoop , E , van Diemen , N G J , Libourel , E J , Geraedts , E J , Bootsma , G P , van der Leest , C H , Peerdeman , A L , Herbschleb , K H , Visser , O J , Bloemendal , H J , van Laarhoven , H W M , de Vries , E G E , Hendriks , L E L , Beerepoot , L V , Westgeest , H M , van den Berkmortel , F W P J , Dingemans , A M C , van der Veldt , A A M , van Leeuwen , L , van der Meer , F S , Tiemessen , M A , van Diepen , D M , Brocken , P , Drooger , J C , de Groot , J W B , Stigt , J A , Slingerland , M , Haberkorn , B C M , Aarts , M J B , Youssef , M , Faber , L M , van de Wetering , R A W , Bard , M P L , Douma , G , Suijkerbuijk , K P M , Bakker , S D , de Jong , W K , Staal , A J & Franken , B 2022 , ' Life-prolonging treatment restrictions and outcomes in patients wi....  , 2022
 
?
14

The thalamus and its subnuclei—a gateway to obsessive-compu..:

Weeland, Cees J ; Kasprzak, Selina ; de Joode, Niels T...
ENIGMA OCD Working Group , Weeland , C J , Kasprzak , S , de Joode , N T , Abe , Y , Alonso , P , Ameis , S H , Anticevic , A , Arnold , P D , Balachander , S , Banaj , N , Bargallo , N , Batistuzzo , M C , Benedetti , F , Beucke , J C , Bollettini , I , Brecke , V , Brem , S , Cappi , C , Cheng , Y , Cho , K I K , Costa , D L C , Dallaspezia , S , Denys , D , Eng , G K , Ferreira , S , Feusner , J D , Fontaine , M , Fouche , J P , Grazioplene , R G , Gruner , P , He , M , Hirano , Y , Hoexter , M Q , Huyser , C , Hu , H , Jaspers-Fayer , F , Kathmann , N , Kaufmann , C , Kim , M , Koch , K , Bin Kwak , Y , Kwon , J S , Lazaro , L , Li , C S R , Lochner , C , Marsh , R , Martínez-Zalacaín , I , Mataix-Cols , D , Menchón , J M & White , T 2022 , ' The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder ' , Translational Psychiatry , vol. 12 , no. 1 , 70 . https://doi.org/10.1038/s41398-022-01823-2.  , 2022
 
?
15

Early discontinuation of PD-1 blockade upon achieving a com..:

Mulder, E. E. A. P ; de Joode, K ; Litiere, S...
Mulder , E E A P , de Joode , K , Litiere , S , ten Tije , A J , Suijkerbuijk , K P M , Boers-Sonderen , M J , Hospers , G A P , de Groot , J W B , van den Eertwegh , A J M , Aarts , M J B , Piersma , D , van Rijn , R S , Kapiteijn , E , Vreugdenhil , G , van den Berkmortel , F W P J , Oomen-de Hoop , E , Franken , M G , Ryll , B , Rutkowski , P , Sleijfer , S , Haanen , J B A G & van der Veldt , A A M 2021 , ' Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma : the multicentre prospective Safe Stop trial ' , BMC Cancer , vol. 21 , no. 1 , 323 . https://doi.org/10.1186/s12885-021-08018-w.  , 2021
 
1-15